Archive by Author

India & RCEP: The end of low cost medications?

India & RCEP: The end of low cost medications?
Share

India’s pharmaceutical industry will be limited by the proposed TRIPS Plus clauses within the Regional Comprehensive Economic Partnership (RCEP) between ASEAN and their trading partners. These would make large production more complex causing medicine prices to go up and thus rendering them less accessible, especially for people living in developing countries. The RCEP is a […]

Read More 0 Comments